SMR SHOULDER
Report
- Report Number
- 3008021110-2026-00208
- Event Type
- Injury
- Date Received
- May 18, 2026
- Date of Event
- March 18, 2026
- Report Date
- May 18, 2026
- Manufacturer
- LIMACORPORATE S.P.A
- Product Code
- PHX
- UDI-DI
- 08033390102940
- PMA / PMN Number
- K142139
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
PRELIMINARY REVIEW OF MANUFACTURING RECORDS DID NOT IDENTIFY ANY PRE-EXISTING NON-CONFORMITY THAT COULD HAVE CONTRIBUTED TO REPORTED ISSUE. THE MANUFACTURER WILL SUBMIT A FINAL REPORT AS SOON AS THE INVESTIGATION IS COMPLETED.
REVISION SURGERY WAS PERFORMED ON (B)(6) 2026 DUE TO SHOULDER DISLOCATION. PREVIOUS SURGERY OCCURRED ON (B)(6) 2023 FOR A REVERSE TOTAL SHOULDER ARTHROPLASTY, WITH FOLLOWING COMPONENTS: - SMR TT BASEPLATE SMALL-R (PN 1375.15.605), - SMR GLENOID PEG TT SMALL-R #MEDIUM (PN 1375.14.652), - CONNECTOR LAR +2MM SMALL-R (PN 1374.15.312), - GLENOSPHERE DIA40MM (PN 1374.09.121, LOT 2213444, STERILIZATION (B)(4)), - FINNED STEM SHORT DIA25MM (PN 1304.15.025), - 140° REVERSE HUMERAL BODY (PN 1352.15.011). - REVERSE LINER +6MM DIA40MM (PN 1365.50.820, LOT 22AT0WC, STERILIZATION (B)(4)). AROUND 3 YEARS AFTER PREVIOUS SURGERY, PATIENT DISLOCATED. PRE-EXISTING CONNECTOR, GLENOSPHERE, REVERSE HUMERAL BODY AND LINER WERE REMOVED AND REPLACED WITH A MORE LATERALIZED AND THICK ASSEMBLY CONSISTING OF: - CONNECTOR LAT +4MM (PN 1374.15.314), - GLENOSPHERE ECCENTRICAL DIA 40MM (PN 1376.09.041), - 140° REVERSE HUMERAL BODY (PN 1352.15.011), - EXTENSION FOR HUMERAL REVERSE BODY (PN 1352.15.001), - REVERSE LINER +6MM DIA40MM (PN 1365.50.820). SURGERY WAS COMPLETED AS INTENDED. PATIENT IS MALE, DATE OF BIRTH (B)(6) 1953. THE EVENT OCCURRED IN THE UNITED STATES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 384055 | SMR SHOULDER | REVERSE LINER 40MM +6MM | PHX | LIMACORPORATE S.P.A | 1365.50.820 | 22AT0WC | 08033390102940 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |